RFG Advisory’s National Health Investors NHI Stock Holding History

RFG Advisory’s Portfolio NHI Stock Details NHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,809	Closed	-$255K	–	439
2021 Q2	$255K	Sell	3,809 -145	-4%	-$10.1K	0.02%	380
2021 Q1	$286K	Sell	3,954 -890	-18%	-$62.1K	0.03%	345
2020 Q4	$323K	Buy	4,844 +190	+4%	+$12.1K	0.04%	316
2020 Q3	$280K	Buy	+4,654	New	+$287K	0.04%	326

Other funds holding NHI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RFG Advisory's NHI Position: Q3 2021 in Review

RFG Advisory sold out of National Health Investors (NHI) in Q3 2021, closing a stake of 3,809 shares — an estimated $255K sold.

RFG Advisory first reported a position in NHI in Q3 2020 and held it in 4 quarters. The position peaked at $323K in Q4 2020. 239 funds tracked by Wall St. Rank hold NHI as of Q3 2021.

RFG Advisory reported no remaining National Health Investors position as of Q3 2021 after selling out during the quarter.
RFG Advisory sold 3,809 National Health Investors shares in Q3 2021, an estimated $255K.
RFG Advisory first reported a position in National Health Investors in Q3 2020 and held it in 4 quarters.
RFG Advisory's National Health Investors position peaked at $323K in Q4 2020.
239 funds tracked by Wall St. Rank held National Health Investors as of Q3 2021.

Based on RFG Advisory's 13F filing for Q3 2021, filed 19 Oct 2021.